GDNF-RELATED FACTORS AND RECEPTORS
GDNF 相关因子和受体
基本信息
- 批准号:6243414
- 负责人:
- 金额:$ 12.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-07-01 至 1998-06-30
- 项目状态:已结题
- 来源:
- 关键词:Parkinson's disease basal ganglia cell senescence chick embryo corpus striatum disease /disorder model dopamine dopamine agonists gene targeting glia growth factor receptors immunocytochemistry in situ hybridization laboratory mouse laboratory rabbit nervous system transplantation neurogenesis neurotransmitter transport neurotrophic factors substantia nigra tissue /cell culture transfection transforming growth factors
项目摘要
The objective of this project is an understanding of the neurotrophic
support responsible for the development and maintenance of the
nigrostriatal dopamine system. A central working hypothesis of Project 4
states that glial cell line-derived neurotrophic factor (GDNF) is the
endogenous dopaminotrophic factor. This hypothesis leads to four
postulates; 1) Exogenous GDNF must exert dopaminotrophic activity in
vivo: This postulate is tested by a series of intraocular brain tissue
grafting experiments. We will test the effect of neuron age as well as the
effect of GDNF on target specificity and target=-elicited fiber growth in
the intraocular model. 2a) GDNF must be expressed in the appropriate
dopamine target areas: This postulate is tested by mapping the expression
of GDNF mRNA by in situ hybridization and the presence of GDNF protein by
immunohistochemistry. Treatment with neuroexcitatory drugs will test if
GDNF expression in striatum is regulated. 2b) GDNF must be taken up by
dopamine nerve terminals and transported retrogradely to their cell bodies
of origin; The postulate is tested by transport studies using radiolabeled
and unlabelled GDNF and autoradiographic and immunohistochemical detection
methods, respectively. 3) Absence of GDNF must lead to a disturbed
development and/or maintenance of the nigrostriatal dopamine system: This
postulate is tested by a set of gene targeting experiments. We will
generate "classical" knockouts of the GDNF gene. Several ways to handle
the possibility that a "classical" GDNF knockout leads to early lethality,
such as grafting mutated embryonic tissue to healthy animals, cross-
breeding with animals overexpressing GDNF under a muscle-specific promoter
(to rescue motor neurons) or studying heterozygous animals, which might
have a milder phenotype, are also proposed. Using the Cre-loxP system,
promoter-driven specific knockouts of the GDNF gene will also be generated.
To cause a null-mutation of the GDNF gene in only neurons, only astrocytes
or only striatum, respectively, we will use the nestin, thy-1 or
neurofilament promoter (neurons), the GFAP promoter (astrocytes) or
specific RARbeta or RXR gamma transcription factor promotors (striatum).
4) GDNF should have unique dopaminotrophic properties: This postulate is
tested by studying the cellular distribution of another cloned TGFbeta
superfamily member, OP-1. Additionally, the cloned OP01 receptor BMPR-type
II will be mapped. Taken together, these experiments will provide new
knowledge about the normal trophic support of the nigrostriatal dopamine
system.
这个项目的目的是了解神经营养
负责开发和维护
黑质纹状体多巴胺系统 项目4的核心工作假设
指出胶质细胞源性神经营养因子(GDNF)是
内源性多巴胺营养因子 这一假设导致四个
假设:1)外源性GDNF必须发挥多巴胺营养活性,
体内:这一假设通过一系列眼内脑组织进行了测试。
嫁接实验 我们将测试神经元年龄的影响以及
GDNF对靶特异性和靶诱导的纤维生长的影响
眼内模型。 2a)GDNF必须以适当的
多巴胺靶区:这一假设是通过映射表达测试
GDNF mRNA的原位杂交和GDNF蛋白的存在
免疫组化 神经兴奋性药物治疗将测试是否
GDNF在纹状体中的表达受到调节。 2b)GDNF必须被以下物质摄取:
多巴胺神经末梢和运输逆行到他们的细胞体
通过使用放射性标记的
未标记GDNF及放射自显影和免疫组化检测
方法中选择一个. 3)GDNF的缺失一定会导致
黑质纹状体多巴胺系统的发展和/或维持:这
通过一组基因打靶实验验证了这一假设。 我们将
产生GDNF基因的“经典”敲除。 几种处理方式
“经典”GDNF敲除导致早期致死的可能性,
例如将突变的胚胎组织移植到健康的动物身上,
在肌肉特异性启动子下过表达GDNF的动物繁殖
(to拯救运动神经元)或研究杂合子动物,这可能
有一个温和的表型,也提出了。 使用Cre-loxP系统,
还将产生GDNF基因的启动子驱动的特异性敲除。
只在神经元和星形胶质细胞中引起GDNF基因的无效突变
或仅纹状体,分别,我们将使用巢蛋白,thy-1或
神经丝启动子(神经元)、GFAP启动子(星形胶质细胞)或
特异性RAR β或RXR γ转录因子启动子(纹状体)。
4)GDNF应该具有独特的多巴胺营养特性:这一假设是
通过研究另一种克隆的TGF β的细胞分布进行测试,
超家族成员OP-1 此外,克隆的OP 01受体BMPR型
二是要做地图。 综合起来,这些实验将提供新的
关于黑质纹状体多巴胺的正常营养支持的知识
系统
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LARS OLSON其他文献
LARS OLSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LARS OLSON', 18)}}的其他基金
AGING AND MITOCHONDRIAL RESPIRATORY ENZYME DNA MUTATIONS
衰老与线粒体呼吸酶 DNA 突变
- 批准号:
7092794 - 财政年份:2006
- 资助金额:
$ 12.28万 - 项目类别:
Parkinsonian mouse model: impaired respiratory enzymes
帕金森病小鼠模型:呼吸酶受损
- 批准号:
6911384 - 财政年份:2005
- 资助金额:
$ 12.28万 - 项目类别:
NEUROTROPHIC FACTORS IN AGING AND ALZHEIMER'S DISEASE
衰老和阿尔茨海默病中的神经营养因子
- 批准号:
6311455 - 财政年份:2000
- 资助金额:
$ 12.28万 - 项目类别:
NEUROTROPHIC FACTORS IN AGING AND ALZHEIMER'S DISEASE
衰老和阿尔茨海默病中的神经营养因子
- 批准号:
6097981 - 财政年份:1999
- 资助金额:
$ 12.28万 - 项目类别:
NEUROTROPHIC FACTORS IN AGING AND ALZHEIMER'S DISEASE
衰老和阿尔茨海默病中的神经营养因子
- 批准号:
6267222 - 财政年份:1998
- 资助金额:
$ 12.28万 - 项目类别:
NEUROTROPHIC FACTORS IN AGING AND ALZHEIMER'S DISEASE
衰老和阿尔茨海默病中的神经营养因子
- 批准号:
6233993 - 财政年份:1997
- 资助金额:
$ 12.28万 - 项目类别:
NEUROANATOMY/REGENERATION RELATED TO SPINAL CORD INJURY
与脊髓损伤相关的神经解剖学/再生
- 批准号:
2662863 - 财政年份:1997
- 资助金额:
$ 12.28万 - 项目类别:
NEURONOTROPHIC FACTORS IN AGING AND ALZHEIMER'S DISEASE
衰老和阿尔茨海默病中的神经营养因子
- 批准号:
3802443 - 财政年份:
- 资助金额:
$ 12.28万 - 项目类别:
相似海外基金
Mechanisms of Motivation: The Role of Cortical-Basal Ganglia-Dopamine Circuits in Reward Pursuit and Apathy
动机机制:皮质-基底神经节-多巴胺回路在奖励追求和冷漠中的作用
- 批准号:
MR/X022080/1 - 财政年份:2024
- 资助金额:
$ 12.28万 - 项目类别:
Research Grant
Elucidation of the onset mechanism of dysphagia in basal ganglia disease and development of new treatment methods
阐明基底神经节疾病吞咽困难的发病机制并开发新的治疗方法
- 批准号:
23K09284 - 财政年份:2023
- 资助金额:
$ 12.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Opponent control of action selection in the cortico-basal-ganglia-colliculus loop
皮质-基底节-丘环中动作选择的对手控制
- 批准号:
10633574 - 财政年份:2023
- 资助金额:
$ 12.28万 - 项目类别:
Characterizing GABAergic transmission at the cellular and synaptic levels in the developing and mature basal ganglia of the Huntington's Disease brain
描述亨廷顿病大脑发育和成熟基底神经节细胞和突触水平上的 GABA 能传递
- 批准号:
478477 - 财政年份:2023
- 资助金额:
$ 12.28万 - 项目类别:
Operating Grants
CRCNS: Decision dynamics in cortico-basal ganglia-thalamic networks
CRCNS:皮质-基底节-丘脑网络的决策动态
- 批准号:
10830650 - 财政年份:2023
- 资助金额:
$ 12.28万 - 项目类别:
Basal ganglia circuit mechanisms for threat coping
应对威胁的基底神经节回路机制
- 批准号:
10727893 - 财政年份:2023
- 资助金额:
$ 12.28万 - 项目类别:
The thalamic link between cerebellum and basal ganglia: A new approach to the treatment of dystonia
小脑和基底神经节之间的丘脑联系:治疗肌张力障碍的新方法
- 批准号:
489739 - 财政年份:2023
- 资助金额:
$ 12.28万 - 项目类别:
Operating Grants
Dissecting functional subgroups and closed-loop circuits between the pedunculopontine nucleus and the basal ganglia
解剖桥脚核和基底神经节之间的功能亚组和闭环回路
- 批准号:
10677467 - 财政年份:2023
- 资助金额:
$ 12.28万 - 项目类别:
Cortical basal ganglia network dynamics during human gait control
人类步态控制过程中的皮质基底神经节网络动力学
- 批准号:
10567272 - 财政年份:2023
- 资助金额:
$ 12.28万 - 项目类别:
Circuit-Inspired Strategies to Restore Basal Ganglia Function in Mouse Models of Parkinson’s Disease
恢复帕金森病小鼠模型基底神经节功能的受电路启发的策略
- 批准号:
10665167 - 财政年份:2023
- 资助金额:
$ 12.28万 - 项目类别: